Give Hope Blog

Saul Priceman | City of Hope

City of Hope scientist receives $9.28M for CAR T trial for metastatic breast cancer

August 15, 2019 | Letisia Marquez

Saul Priceman, Ph.D., and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine to support a CAR T cell phase 1 clinical trial for the treatment of women with HER2-positive breast cancer that has spread to the brain.

Continue Reading

Xiuli Wang Profile Headshot - small low res

Researcher awarded grant to study promising new HIV therapy

October 18, 2018 | Samantha Bonar

The California Institute for Regenerative Medicine has awarded City of Hope’s Xiuli Wang, Ph.D., $3.8 million to develop chimeric antigen receptor (CAR) T cells that can target and kill HIV-infected cells.

Continue Reading

Sickle cell anemia | City of Hope

Promising Sickle Cell Research Gets Nearly $6MM Boost from CIRM

March 22, 2018 | Michael Easterling

Thanks to a $5.74 million award from the California Institute for Regenerative Medicine, City of Hope’s Joseph Rosenthal, M.D., and his team can advance their research into finding a cure for sickle cell disease.

Continue Reading

Saswatee Chatterjee

Gene Therapy Shows Promise for Hemophilia

February 21, 2018 | Katie Neith

City of Hope researcher and professor, Saswati Chatterjee, Ph.D., thinks she may know a way to cure hemophilia A.

Continue Reading

Hybrid Nurse Alpha Clinic | City of Hope

City of Hope’s Alpha Clinic Plots ‘the Future of Nursing’

November 3, 2017 | Wayne Lewis

According to a new paper in Stem Cells Translational Medicine, the authors identify the role of a nurse qualified in both patient care and research protocols, the so-called “hybrid nurse” — a homegrown City of Hope innovation — as an important component of their success in the development of the Alpha Clinic.

Continue Reading

Joe Gold, Center for Biomedicine and Genetics, City of Hope

Joe Gold: Stem Cell Champion

July 13, 2017 | Abe Rosenberg

Joseph Gold, Ph.D., is chief overseer of a sprawling, state-of-the-art manufacturing facility cranking out mass quantities of carefully engineered stem cells aimed at curing the most dangerous and debilitating diseases of our time.

Continue Reading

Back To Top